Clinical Trial Update: Safety and Efficacy Study of Panzem® Nanocrystal Colloidal Dispersion in Patients With Ovarian Cancer [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 safety and efficacy study of Panzem Nanocrystal Colloidal Dispersion in patients with ovarian can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Panzem Nanocrystal Colloidal Dispersion (2-methoxyestradiol)

Snippet

Sponsor: CASI Pharmaceuticals, Inc. | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED